![Bernhard Gentner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 713 657 $ op 31-05-2026
Bernhard Gentner is the founder.
Dr. Gentner founded Genenta Science SpA in 2014 and held the title of Member-Executive Scientific Board.
Education includes a doctorate from Baylor College of Medicine and a doctorate from Ruprecht-Karls-Universität Heidelberg.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-05-2026 | 692.871 ( 3,8% ) | 713 657 $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
